| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.557 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
0.557 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
0.557 |
Evidence |
|
| SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.557 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.557 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.557 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.557 |
Evidence |
O
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.557 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.557 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.557 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.557 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.557 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.557 |
Evidence |
|
| FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.557 |
Evidence |
|
| FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.557 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.557 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.557 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.557 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.557 |
Evidence |
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.557 |
Evidence |
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.557 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.557 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.557 |
Evidence |
|